nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—PPARG—colon cancer	0.625	1	CbGaD
Bezafibrate—SLCO1B1—Irinotecan—colon cancer	0.0826	0.443	CbGbCtD
Bezafibrate—SLCO1B1—Methotrexate—colon cancer	0.0437	0.234	CbGbCtD
Bezafibrate—CYP2C8—Fluorouracil—colon cancer	0.0335	0.18	CbGbCtD
Bezafibrate—CYP3A4—Irinotecan—colon cancer	0.0142	0.076	CbGbCtD
Bezafibrate—CYP3A4—Vincristine—colon cancer	0.0124	0.0665	CbGbCtD
Bezafibrate—PPARA—blood vessel—colon cancer	0.00473	0.0702	CbGeAlD
Bezafibrate—PPARG—Topotecan—Irinotecan—colon cancer	0.00387	1	CbGdCrCtD
Bezafibrate—HMGCR—gall bladder—colon cancer	0.00296	0.0439	CbGeAlD
Bezafibrate—PPARA—embryo—colon cancer	0.00282	0.0419	CbGeAlD
Bezafibrate—PPARG—endothelium—colon cancer	0.00282	0.0418	CbGeAlD
Bezafibrate—PPARG—blood vessel—colon cancer	0.0026	0.0386	CbGeAlD
Bezafibrate—PPARA—epithelium—colon cancer	0.0023	0.0342	CbGeAlD
Bezafibrate—PPARA—smooth muscle tissue—colon cancer	0.00222	0.0329	CbGeAlD
Bezafibrate—PPARA—renal system—colon cancer	0.00213	0.0317	CbGeAlD
Bezafibrate—PPARD—lymphoid tissue—colon cancer	0.00208	0.0309	CbGeAlD
Bezafibrate—PPARD—digestive system—colon cancer	0.00205	0.0305	CbGeAlD
Bezafibrate—PPARD—vagina—colon cancer	0.00181	0.0269	CbGeAlD
Bezafibrate—PPARA—lymphoid tissue—colon cancer	0.00177	0.0263	CbGeAlD
Bezafibrate—PPARA—digestive system—colon cancer	0.00175	0.026	CbGeAlD
Bezafibrate—Balsalazide—PPARG—colon cancer	0.00164	0.396	CrCbGaD
Bezafibrate—PPARG—embryo—colon cancer	0.00155	0.023	CbGeAlD
Bezafibrate—HMGCR—epithelium—colon cancer	0.00153	0.0227	CbGeAlD
Bezafibrate—PPARD—liver—colon cancer	0.00153	0.0227	CbGeAlD
Bezafibrate—Serum creatinine increased—Irinotecan—colon cancer	0.00152	0.0283	CcSEcCtD
Bezafibrate—HMGCR—smooth muscle tissue—colon cancer	0.00148	0.0219	CbGeAlD
Bezafibrate—HMGCR—renal system—colon cancer	0.00142	0.0211	CbGeAlD
Bezafibrate—SLCO1B1—renal system—colon cancer	0.00136	0.0202	CbGeAlD
Bezafibrate—PPARA—liver—colon cancer	0.0013	0.0194	CbGeAlD
Bezafibrate—PPARG—epithelium—colon cancer	0.00126	0.0188	CbGeAlD
Bezafibrate—PPARG—smooth muscle tissue—colon cancer	0.00122	0.0181	CbGeAlD
Bezafibrate—HMGCR—lymphoid tissue—colon cancer	0.00118	0.0175	CbGeAlD
Bezafibrate—PPARG—renal system—colon cancer	0.00117	0.0174	CbGeAlD
Bezafibrate—PPARD—lymph node—colon cancer	0.00117	0.0174	CbGeAlD
Bezafibrate—HMGCR—digestive system—colon cancer	0.00116	0.0173	CbGeAlD
Bezafibrate—SLCO1B1—digestive system—colon cancer	0.00112	0.0166	CbGeAlD
Bezafibrate—HMGCR—bone marrow—colon cancer	0.00107	0.0159	CbGeAlD
Bezafibrate—HMGCR—vagina—colon cancer	0.00103	0.0153	CbGeAlD
Bezafibrate—Serum creatinine increased—Capecitabine—colon cancer	0.00102	0.019	CcSEcCtD
Bezafibrate—PPARA—lymph node—colon cancer	0.001	0.0148	CbGeAlD
Bezafibrate—PPARG—lymphoid tissue—colon cancer	0.000974	0.0145	CbGeAlD
Bezafibrate—PPARG—digestive system—colon cancer	0.000962	0.0143	CbGeAlD
Bezafibrate—Phosphatase alkaline increased—Irinotecan—colon cancer	0.000935	0.0174	CcSEcCtD
Bezafibrate—PPARG—bone marrow—colon cancer	0.000887	0.0132	CbGeAlD
Bezafibrate—HMGCR—liver—colon cancer	0.000868	0.0129	CbGeAlD
Bezafibrate—PPARG—vagina—colon cancer	0.00085	0.0126	CbGeAlD
Bezafibrate—SLCO1B1—liver—colon cancer	0.000831	0.0123	CbGeAlD
Bezafibrate—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.00078	0.0145	CcSEcCtD
Bezafibrate—CYP2C8—renal system—colon cancer	0.000773	0.0115	CbGeAlD
Bezafibrate—CYP1A1—epithelium—colon cancer	0.00077	0.0114	CbGeAlD
Bezafibrate—Photosensitivity—Fluorouracil—colon cancer	0.00074	0.0138	CcSEcCtD
Bezafibrate—Renal failure acute—Irinotecan—colon cancer	0.000735	0.0137	CcSEcCtD
Bezafibrate—Indomethacin—PPARG—colon cancer	0.000722	0.175	CrCbGaD
Bezafibrate—PPARG—liver—colon cancer	0.000717	0.0106	CbGeAlD
Bezafibrate—CYP1A1—renal system—colon cancer	0.000714	0.0106	CbGeAlD
Bezafibrate—Balsalazide—PTGS2—colon cancer	0.000691	0.167	CrCbGaD
Bezafibrate—HMGCR—lymph node—colon cancer	0.000665	0.00988	CbGeAlD
Bezafibrate—Blood creatinine increased—Irinotecan—colon cancer	0.000636	0.0119	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000627	0.0117	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Capecitabine—colon cancer	0.000626	0.0117	CcSEcCtD
Bezafibrate—Muscular weakness—Vincristine—colon cancer	0.000614	0.0115	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000611	0.0114	CcSEcCtD
Bezafibrate—Cramp muscle—Irinotecan—colon cancer	0.000611	0.0114	CcSEcCtD
Bezafibrate—CYP1A1—digestive system—colon cancer	0.000586	0.0087	CbGeAlD
Bezafibrate—Muscular weakness—Fluorouracil—colon cancer	0.000573	0.0107	CcSEcCtD
Bezafibrate—Pancytopenia—Vincristine—colon cancer	0.000572	0.0107	CcSEcCtD
Bezafibrate—CYP2C8—vagina—colon cancer	0.00056	0.00832	CbGeAlD
Bezafibrate—Erectile dysfunction—Vincristine—colon cancer	0.000555	0.0103	CcSEcCtD
Bezafibrate—PPARG—lymph node—colon cancer	0.00055	0.00816	CbGeAlD
Bezafibrate—Photosensitivity reaction—Vincristine—colon cancer	0.00055	0.0102	CcSEcCtD
Bezafibrate—Pancytopenia—Fluorouracil—colon cancer	0.000533	0.00994	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Vincristine—colon cancer	0.000529	0.00987	CcSEcCtD
Bezafibrate—Myocardial infarction—Vincristine—colon cancer	0.000526	0.00981	CcSEcCtD
Bezafibrate—CYP3A4—renal system—colon cancer	0.000524	0.00778	CbGeAlD
Bezafibrate—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000522	0.00973	CcSEcCtD
Bezafibrate—CYP1A1—vagina—colon cancer	0.000517	0.00768	CbGeAlD
Bezafibrate—Photosensitivity—Capecitabine—colon cancer	0.000517	0.00964	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Irinotecan—colon cancer	0.000515	0.00961	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Fluorouracil—colon cancer	0.000513	0.00956	CcSEcCtD
Bezafibrate—Myocardial infarction—Irinotecan—colon cancer	0.000512	0.00956	CcSEcCtD
Bezafibrate—Vascular purpura—Capecitabine—colon cancer	0.000508	0.00946	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Fluorouracil—colon cancer	0.000494	0.0092	CcSEcCtD
Bezafibrate—Renal failure acute—Capecitabine—colon cancer	0.000492	0.00917	CcSEcCtD
Bezafibrate—Myocardial infarction—Fluorouracil—colon cancer	0.000491	0.00915	CcSEcCtD
Bezafibrate—Urinary tract disorder—Vincristine—colon cancer	0.000476	0.00887	CcSEcCtD
Bezafibrate—CYP2C8—liver—colon cancer	0.000473	0.00702	CbGeAlD
Bezafibrate—Urethral disorder—Vincristine—colon cancer	0.000472	0.00881	CcSEcCtD
Bezafibrate—Purpura—Capecitabine—colon cancer	0.000471	0.00878	CcSEcCtD
Bezafibrate—Migraine—Capecitabine—colon cancer	0.000447	0.00833	CcSEcCtD
Bezafibrate—Pharyngitis—Fluorouracil—colon cancer	0.000446	0.00832	CcSEcCtD
Bezafibrate—CYP1A1—liver—colon cancer	0.000436	0.00648	CbGeAlD
Bezafibrate—CYP3A4—digestive system—colon cancer	0.00043	0.00638	CbGeAlD
Bezafibrate—Alopecia—Vincristine—colon cancer	0.000426	0.00794	CcSEcCtD
Bezafibrate—Blood creatinine increased—Capecitabine—colon cancer	0.000425	0.00793	CcSEcCtD
Bezafibrate—Liver function test abnormal—Capecitabine—colon cancer	0.000419	0.00782	CcSEcCtD
Bezafibrate—Alopecia—Irinotecan—colon cancer	0.000415	0.00773	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000409	0.00762	CcSEcCtD
Bezafibrate—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000409	0.00762	CcSEcCtD
Bezafibrate—Flatulence—Irinotecan—colon cancer	0.000403	0.00751	CcSEcCtD
Bezafibrate—Gastritis—Capecitabine—colon cancer	0.000402	0.00749	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Capecitabine—colon cancer	0.0004	0.00747	CcSEcCtD
Bezafibrate—Muscular weakness—Capecitabine—colon cancer	0.0004	0.00747	CcSEcCtD
Bezafibrate—Alopecia—Fluorouracil—colon cancer	0.000397	0.00741	CcSEcCtD
Bezafibrate—Muscle spasms—Irinotecan—colon cancer	0.000393	0.00732	CcSEcCtD
Bezafibrate—Influenza—Capecitabine—colon cancer	0.000392	0.00732	CcSEcCtD
Bezafibrate—Erythema—Fluorouracil—colon cancer	0.000391	0.0073	CcSEcCtD
Bezafibrate—Anaemia—Vincristine—colon cancer	0.000388	0.00723	CcSEcCtD
Bezafibrate—Photosensitivity—Methotrexate—colon cancer	0.000385	0.00718	CcSEcCtD
Bezafibrate—Anaemia—Irinotecan—colon cancer	0.000378	0.00704	CcSEcCtD
Bezafibrate—Bronchitis—Capecitabine—colon cancer	0.000377	0.00704	CcSEcCtD
Bezafibrate—Pancytopenia—Capecitabine—colon cancer	0.000373	0.00695	CcSEcCtD
Bezafibrate—Renal failure acute—Methotrexate—colon cancer	0.000366	0.00683	CcSEcCtD
Bezafibrate—Anaemia—Fluorouracil—colon cancer	0.000362	0.00674	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Capecitabine—colon cancer	0.000358	0.00668	CcSEcCtD
Bezafibrate—Myalgia—Vincristine—colon cancer	0.000357	0.00666	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000347	0.00647	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Capecitabine—colon cancer	0.000345	0.00643	CcSEcCtD
Bezafibrate—Myocardial infarction—Capecitabine—colon cancer	0.000343	0.0064	CcSEcCtD
Bezafibrate—Infection—Vincristine—colon cancer	0.00034	0.00634	CcSEcCtD
Bezafibrate—Thrombocytopenia—Vincristine—colon cancer	0.000335	0.00625	CcSEcCtD
Bezafibrate—CYP1A1—lymph node—colon cancer	0.000335	0.00497	CbGeAlD
Bezafibrate—Myalgia—Fluorouracil—colon cancer	0.000333	0.00621	CcSEcCtD
Bezafibrate—Infection—Irinotecan—colon cancer	0.000331	0.00618	CcSEcCtD
Bezafibrate—Thrombocytopenia—Irinotecan—colon cancer	0.000326	0.00609	CcSEcCtD
Bezafibrate—CYP3A4—liver—colon cancer	0.00032	0.00475	CbGeAlD
Bezafibrate—Infection—Fluorouracil—colon cancer	0.000317	0.00592	CcSEcCtD
Bezafibrate—Thrombocytopenia—Fluorouracil—colon cancer	0.000313	0.00583	CcSEcCtD
Bezafibrate—Liver function test abnormal—Methotrexate—colon cancer	0.000312	0.00582	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Vincristine—colon cancer	0.000312	0.00582	CcSEcCtD
Bezafibrate—Pharyngitis—Capecitabine—colon cancer	0.000312	0.00581	CcSEcCtD
Bezafibrate—Urinary tract disorder—Capecitabine—colon cancer	0.00031	0.00578	CcSEcCtD
Bezafibrate—Insomnia—Vincristine—colon cancer	0.00031	0.00577	CcSEcCtD
Bezafibrate—Urethral disorder—Capecitabine—colon cancer	0.000308	0.00574	CcSEcCtD
Bezafibrate—Indomethacin—PTGS2—colon cancer	0.000305	0.0738	CrCbGaD
Bezafibrate—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000304	0.00568	CcSEcCtD
Bezafibrate—Insomnia—Irinotecan—colon cancer	0.000302	0.00562	CcSEcCtD
Bezafibrate—Erythema multiforme—Capecitabine—colon cancer	0.000297	0.00554	CcSEcCtD
Bezafibrate—Dyspepsia—Irinotecan—colon cancer	0.000294	0.00547	CcSEcCtD
Bezafibrate—Pain—Vincristine—colon cancer	0.000293	0.00546	CcSEcCtD
Bezafibrate—Constipation—Vincristine—colon cancer	0.000293	0.00546	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000291	0.00543	CcSEcCtD
Bezafibrate—Insomnia—Fluorouracil—colon cancer	0.000289	0.00539	CcSEcCtD
Bezafibrate—Pain—Irinotecan—colon cancer	0.000285	0.00532	CcSEcCtD
Bezafibrate—Constipation—Irinotecan—colon cancer	0.000285	0.00532	CcSEcCtD
Bezafibrate—Aminohippurate—ABCB1—colon cancer	0.000282	0.0684	CrCbGaD
Bezafibrate—Dyspepsia—Fluorouracil—colon cancer	0.000281	0.00524	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Vincristine—colon cancer	0.00028	0.00522	CcSEcCtD
Bezafibrate—Alopecia—Capecitabine—colon cancer	0.000278	0.00518	CcSEcCtD
Bezafibrate—Pancytopenia—Methotrexate—colon cancer	0.000277	0.00517	CcSEcCtD
Bezafibrate—Erythema—Capecitabine—colon cancer	0.000273	0.0051	CcSEcCtD
Bezafibrate—Pain—Fluorouracil—colon cancer	0.000273	0.00509	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Irinotecan—colon cancer	0.000273	0.00508	CcSEcCtD
Bezafibrate—Abdominal pain—Vincristine—colon cancer	0.000271	0.00505	CcSEcCtD
Bezafibrate—Flatulence—Capecitabine—colon cancer	0.000269	0.00502	CcSEcCtD
Bezafibrate—Erectile dysfunction—Methotrexate—colon cancer	0.000269	0.00502	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Methotrexate—colon cancer	0.000267	0.00497	CcSEcCtD
Bezafibrate—Abdominal pain—Irinotecan—colon cancer	0.000264	0.00491	CcSEcCtD
Bezafibrate—Muscle spasms—Capecitabine—colon cancer	0.000263	0.0049	CcSEcCtD
Bezafibrate—Indomethacin—ABCB1—colon cancer	0.000259	0.0627	CrCbGaD
Bezafibrate—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000258	0.00482	CcSEcCtD
Bezafibrate—Urticaria—Fluorouracil—colon cancer	0.000254	0.00473	CcSEcCtD
Bezafibrate—Anaemia—Capecitabine—colon cancer	0.000253	0.00471	CcSEcCtD
Bezafibrate—Hypersensitivity—Vincristine—colon cancer	0.000252	0.0047	CcSEcCtD
Bezafibrate—HMGCR—TOR Signaling—AKT1—colon cancer	0.000248	0.00415	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Irinotecan—colon cancer	0.000246	0.00458	CcSEcCtD
Bezafibrate—Hypersensitivity—Fluorouracil—colon cancer	0.000235	0.00439	CcSEcCtD
Bezafibrate—PPARA—PPARA activates gene expression—PPARG—colon cancer	0.000235	0.00393	CbGpPWpGaD
Bezafibrate—Diarrhoea—Vincristine—colon cancer	0.000234	0.00437	CcSEcCtD
Bezafibrate—Glyburide—ABCB1—colon cancer	0.000234	0.0566	CrCbGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—CCND1—colon cancer	0.000233	0.00389	CbGpPWpGaD
Bezafibrate—Myalgia—Capecitabine—colon cancer	0.000233	0.00434	CcSEcCtD
Bezafibrate—Pharyngitis—Methotrexate—colon cancer	0.000232	0.00433	CcSEcCtD
Bezafibrate—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—colon cancer	0.000231	0.00386	CbGpPWpGaD
Bezafibrate—Urinary tract disorder—Methotrexate—colon cancer	0.000231	0.00431	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—CTNNB1—colon cancer	0.000231	0.00385	CbGpPWpGaD
Bezafibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.00023	0.00384	CbGpPWpGaD
Bezafibrate—Urethral disorder—Methotrexate—colon cancer	0.000229	0.00427	CcSEcCtD
Bezafibrate—Diarrhoea—Irinotecan—colon cancer	0.000228	0.00425	CcSEcCtD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—BAX—colon cancer	0.000227	0.00379	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—HNF4A—colon cancer	0.000227	0.00379	CbGpPWpGaD
Bezafibrate—Dizziness—Vincristine—colon cancer	0.000226	0.00422	CcSEcCtD
Bezafibrate—Pruritus—Fluorouracil—colon cancer	0.000226	0.00421	CcSEcCtD
Bezafibrate—Infection—Capecitabine—colon cancer	0.000222	0.00413	CcSEcCtD
Bezafibrate—Erythema multiforme—Methotrexate—colon cancer	0.000221	0.00412	CcSEcCtD
Bezafibrate—CYP3A4—Irinotecan Pathway—APC—colon cancer	0.000221	0.00368	CbGpPWpGaD
Bezafibrate—Dizziness—Irinotecan—colon cancer	0.00022	0.00411	CcSEcCtD
Bezafibrate—Diarrhoea—Fluorouracil—colon cancer	0.000219	0.00407	CcSEcCtD
Bezafibrate—Thrombocytopenia—Capecitabine—colon cancer	0.000219	0.00407	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—CCND1—colon cancer	0.000218	0.00364	CbGpPWpGaD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—CTNNB1—colon cancer	0.000216	0.00361	CbGpPWpGaD
Bezafibrate—Rash—Vincristine—colon cancer	0.000216	0.00403	CcSEcCtD
Bezafibrate—Dermatitis—Vincristine—colon cancer	0.000216	0.00402	CcSEcCtD
Bezafibrate—Headache—Vincristine—colon cancer	0.000214	0.004	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—EP300—colon cancer	0.000214	0.00358	CbGpPWpGaD
Bezafibrate—Dizziness—Fluorouracil—colon cancer	0.000211	0.00394	CcSEcCtD
Bezafibrate—Rash—Irinotecan—colon cancer	0.00021	0.00392	CcSEcCtD
Bezafibrate—Dermatitis—Irinotecan—colon cancer	0.00021	0.00392	CcSEcCtD
Bezafibrate—Headache—Irinotecan—colon cancer	0.000209	0.00389	CcSEcCtD
Bezafibrate—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000208	0.00348	CbGpPWpGaD
Bezafibrate—Alopecia—Methotrexate—colon cancer	0.000207	0.00385	CcSEcCtD
Bezafibrate—PPARA—Adipogenesis—PPARG—colon cancer	0.000206	0.00344	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TYMS—colon cancer	0.000205	0.00342	CbGpPWpGaD
Bezafibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	0.000205	0.00342	CbGpPWpGaD
Bezafibrate—Erythema—Methotrexate—colon cancer	0.000204	0.0038	CcSEcCtD
Bezafibrate—Nausea—Vincristine—colon cancer	0.000203	0.00379	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000203	0.00379	CcSEcCtD
Bezafibrate—Insomnia—Capecitabine—colon cancer	0.000202	0.00376	CcSEcCtD
Bezafibrate—Rash—Fluorouracil—colon cancer	0.000201	0.00375	CcSEcCtD
Bezafibrate—Dermatitis—Fluorouracil—colon cancer	0.000201	0.00375	CcSEcCtD
Bezafibrate—PPARD—Metabolism—CHST5—colon cancer	0.000201	0.00335	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ODC1—colon cancer	0.000201	0.00335	CbGpPWpGaD
Bezafibrate—Headache—Fluorouracil—colon cancer	0.0002	0.00373	CcSEcCtD
Bezafibrate—Nausea—Irinotecan—colon cancer	0.000198	0.00369	CcSEcCtD
Bezafibrate—Dyspepsia—Capecitabine—colon cancer	0.000196	0.00366	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—BRAF—colon cancer	0.000194	0.00325	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—DCC—colon cancer	0.000193	0.00323	CbGpPWpGaD
Bezafibrate—Constipation—Capecitabine—colon cancer	0.000191	0.00356	CcSEcCtD
Bezafibrate—Pain—Capecitabine—colon cancer	0.000191	0.00356	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CDH1—colon cancer	0.00019	0.00318	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—CTNNB1—colon cancer	0.00019	0.00317	CbGpPWpGaD
Bezafibrate—Nausea—Fluorouracil—colon cancer	0.00019	0.00354	CcSEcCtD
Bezafibrate—Anaemia—Methotrexate—colon cancer	0.000188	0.00351	CcSEcCtD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—MYC—colon cancer	0.000187	0.00312	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—CDKN1A—colon cancer	0.000186	0.0031	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Capecitabine—colon cancer	0.000182	0.0034	CcSEcCtD
Bezafibrate—PPARD—Ectoderm Differentiation—CTNNB1—colon cancer	0.000181	0.00303	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CA7—colon cancer	0.000181	0.00302	CbGpPWpGaD
Bezafibrate—HMGCR—SREBP signalling—PIK3CA—colon cancer	0.000181	0.00302	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—PIK3CA—colon cancer	0.000181	0.00302	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CCND1—colon cancer	0.00018	0.00301	CbGpPWpGaD
Bezafibrate—PPARA—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	0.000178	0.00297	CbGpPWpGaD
Bezafibrate—Urticaria—Capecitabine—colon cancer	0.000177	0.00331	CcSEcCtD
Bezafibrate—Abdominal pain—Capecitabine—colon cancer	0.000176	0.00329	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—MYC—colon cancer	0.000175	0.00292	CbGpPWpGaD
Bezafibrate—HMGCR—AMPK Signaling—TP53—colon cancer	0.000175	0.00292	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—CDKN1A—colon cancer	0.000174	0.00291	CbGpPWpGaD
Bezafibrate—Myalgia—Methotrexate—colon cancer	0.000173	0.00323	CcSEcCtD
Bezafibrate—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000173	0.0029	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—HNF4A—colon cancer	0.000173	0.00289	CbGpPWpGaD
Bezafibrate—HMGCR—PPARA activates gene expression—EP300—colon cancer	0.000168	0.00281	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ODC1—colon cancer	0.000167	0.00279	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CHST5—colon cancer	0.000167	0.00279	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of retinoblastoma protein—EP300—colon cancer	0.000166	0.00277	CbGpPWpGaD
Bezafibrate—Infection—Methotrexate—colon cancer	0.000165	0.00308	CcSEcCtD
Bezafibrate—HMGCR—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000165	0.00275	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Capecitabine—colon cancer	0.000164	0.00307	CcSEcCtD
Bezafibrate—PPARA—Developmental Biology—HNF4A—colon cancer	0.000163	0.00272	CbGpPWpGaD
Bezafibrate—Thrombocytopenia—Methotrexate—colon cancer	0.000163	0.00303	CcSEcCtD
Bezafibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000158	0.00265	CbGpPWpGaD
Bezafibrate—PPARG—Signaling events mediated by HDAC Class I—EP300—colon cancer	0.000158	0.00264	CbGpPWpGaD
Bezafibrate—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000158	0.00264	CbGpPWpGaD
Bezafibrate—Pruritus—Capecitabine—colon cancer	0.000158	0.00294	CcSEcCtD
Bezafibrate—PPARA—PPARA activates gene expression—EP300—colon cancer	0.000154	0.00257	CbGpPWpGaD
Bezafibrate—PPARD—Adipogenesis—TGFB1—colon cancer	0.000153	0.00256	CbGpPWpGaD
Bezafibrate—CYP3A4—Metapathway biotransformation—CHST5—colon cancer	0.000153	0.00256	CbGpPWpGaD
Bezafibrate—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—colon cancer	0.000153	0.00256	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ODC1—colon cancer	0.000153	0.00255	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CHST5—colon cancer	0.000153	0.00255	CbGpPWpGaD
Bezafibrate—Diarrhoea—Capecitabine—colon cancer	0.000153	0.00285	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000151	0.00282	CcSEcCtD
Bezafibrate—PPARA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.00015	0.00251	CbGpPWpGaD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.00015	0.00251	CbGpPWpGaD
Bezafibrate—Insomnia—Methotrexate—colon cancer	0.00015	0.0028	CcSEcCtD
Bezafibrate—Dizziness—Capecitabine—colon cancer	0.000148	0.00275	CcSEcCtD
Bezafibrate—HMGCR—AMPK Signaling—AKT1—colon cancer	0.000148	0.00247	CbGpPWpGaD
Bezafibrate—HMGCR—SREBP signalling—AKT1—colon cancer	0.000148	0.00247	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TYMS—colon cancer	0.000147	0.00245	CbGpPWpGaD
Bezafibrate—PPARD—Ectoderm Differentiation—MYC—colon cancer	0.000147	0.00245	CbGpPWpGaD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	0.000147	0.00245	CbGpPWpGaD
Bezafibrate—Dyspepsia—Methotrexate—colon cancer	0.000146	0.00273	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CASP3—colon cancer	0.000146	0.00243	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—PPARG—colon cancer	0.000145	0.00242	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—CTNNB1—colon cancer	0.000145	0.00242	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CA7—colon cancer	0.000142	0.00238	CbGpPWpGaD
Bezafibrate—Pain—Methotrexate—colon cancer	0.000142	0.00265	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CCND1—colon cancer	0.000142	0.00237	CbGpPWpGaD
Bezafibrate—PPARA—Adipogenesis—CDKN1A—colon cancer	0.000141	0.00236	CbGpPWpGaD
Bezafibrate—Rash—Capecitabine—colon cancer	0.000141	0.00262	CcSEcCtD
Bezafibrate—Dermatitis—Capecitabine—colon cancer	0.000141	0.00262	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—colon cancer	0.00014	0.00235	CbGpPWpGaD
Bezafibrate—PPARD—NRF2 pathway—TGFB1—colon cancer	0.00014	0.00234	CbGpPWpGaD
Bezafibrate—Headache—Capecitabine—colon cancer	0.00014	0.00261	CcSEcCtD
Bezafibrate—PPARG—Developmental Biology—DCC—colon cancer	0.000139	0.00232	CbGpPWpGaD
Bezafibrate—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000136	0.00227	CbGpPWpGaD
Bezafibrate—Gastrointestinal pain—Methotrexate—colon cancer	0.000136	0.00253	CcSEcCtD
Bezafibrate—Nausea—Capecitabine—colon cancer	0.000133	0.00247	CcSEcCtD
Bezafibrate—Urticaria—Methotrexate—colon cancer	0.000132	0.00246	CcSEcCtD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—colon cancer	0.000131	0.00219	CbGpPWpGaD
Bezafibrate—Abdominal pain—Methotrexate—colon cancer	0.000131	0.00245	CcSEcCtD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—EP300—colon cancer	0.00013	0.00218	CbGpPWpGaD
Bezafibrate—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	0.000127	0.00213	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—HNF4A—colon cancer	0.000124	0.00207	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—VEGFA—colon cancer	0.000124	0.00207	CbGpPWpGaD
Bezafibrate—CYP1A1—Arachidonic acid metabolism—PTGS2—colon cancer	0.000123	0.00205	CbGpPWpGaD
Bezafibrate—Hypersensitivity—Methotrexate—colon cancer	0.000122	0.00228	CcSEcCtD
Bezafibrate—PPARG—Wnt Signaling Pathway Netpath—AKT1—colon cancer	0.000121	0.00203	CbGpPWpGaD
Bezafibrate—PPARG—SREBP signalling—PIK3CA—colon cancer	0.000118	0.00198	CbGpPWpGaD
Bezafibrate—Pruritus—Methotrexate—colon cancer	0.000118	0.00219	CcSEcCtD
Bezafibrate—PPARA—Adipogenesis—TGFB1—colon cancer	0.000117	0.00195	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HNF4A—colon cancer	0.000117	0.00195	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—colon cancer	0.000115	0.00192	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—MYC—colon cancer	0.000114	0.0019	CbGpPWpGaD
Bezafibrate—Diarrhoea—Methotrexate—colon cancer	0.000114	0.00212	CcSEcCtD
Bezafibrate—HMGCR—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000113	0.00189	CbGpPWpGaD
Bezafibrate—CYP2C8—Arachidonic acid metabolism—PTGS2—colon cancer	0.000113	0.00188	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—EGFR—colon cancer	0.000111	0.00186	CbGpPWpGaD
Bezafibrate—PPARG—PPARA activates gene expression—EP300—colon cancer	0.00011	0.00184	CbGpPWpGaD
Bezafibrate—Dizziness—Methotrexate—colon cancer	0.00011	0.00205	CcSEcCtD
Bezafibrate—PPARG—Metabolism—CHST5—colon cancer	0.00011	0.00183	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ODC1—colon cancer	0.00011	0.00183	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—HNF4A—colon cancer	0.000109	0.00183	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—EP300—colon cancer	0.000109	0.00183	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—colon cancer	0.000109	0.00183	CbGpPWpGaD
Bezafibrate—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000108	0.0018	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—colon cancer	0.000106	0.00178	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—SRC—colon cancer	0.000106	0.00178	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—KRAS—colon cancer	0.000105	0.00176	CbGpPWpGaD
Bezafibrate—Rash—Methotrexate—colon cancer	0.000105	0.00195	CcSEcCtD
Bezafibrate—Dermatitis—Methotrexate—colon cancer	0.000105	0.00195	CcSEcCtD
Bezafibrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.000105	0.00175	CbGpPWpGaD
Bezafibrate—Headache—Methotrexate—colon cancer	0.000104	0.00194	CcSEcCtD
Bezafibrate—PPARG—Adipogenesis—CTNNB1—colon cancer	0.000104	0.00173	CbGpPWpGaD
Bezafibrate—PPARA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000104	0.00173	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—colon cancer	0.000103	0.00173	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—colon cancer	0.000102	0.00171	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—CDKN1A—colon cancer	0.000101	0.00169	CbGpPWpGaD
Bezafibrate—Nausea—Methotrexate—colon cancer	9.87e-05	0.00184	CcSEcCtD
Bezafibrate—PPARD—Generic Transcription Pathway—PPARG—colon cancer	9.85e-05	0.00165	CbGpPWpGaD
Bezafibrate—PPARG—SREBP signalling—AKT1—colon cancer	9.67e-05	0.00162	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—colon cancer	9.52e-05	0.00159	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—colon cancer	9.5e-05	0.00159	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—EP300—colon cancer	9.49e-05	0.00159	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—TP53—colon cancer	9.34e-05	0.00156	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—colon cancer	9.31e-05	0.00156	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—colon cancer	9.31e-05	0.00156	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CA7—colon cancer	8.93e-05	0.00149	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—colon cancer	8.8e-05	0.00147	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ODC1—colon cancer	8.63e-05	0.00144	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CHST5—colon cancer	8.63e-05	0.00144	CbGpPWpGaD
Bezafibrate—PPARA—Transmembrane transport of small molecules—ABCB1—colon cancer	8.63e-05	0.00144	CbGpPWpGaD
Bezafibrate—PPARG—Adipogenesis—TGFB1—colon cancer	8.38e-05	0.0014	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—HNF4A—colon cancer	8.33e-05	0.00139	CbGpPWpGaD
Bezafibrate—CYP1A1—PPARA activates gene expression—PPARG—colon cancer	8.31e-05	0.00139	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PPARG—colon cancer	8.28e-05	0.00138	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CA7—colon cancer	8.18e-05	0.00137	CbGpPWpGaD
Bezafibrate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	8.14e-05	0.00136	CbGpPWpGaD
Bezafibrate—HMGCR—Integrated Breast Cancer Pathway—AKT1—colon cancer	7.89e-05	0.00132	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—PPARG—colon cancer	7.51e-05	0.00125	CbGpPWpGaD
Bezafibrate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—colon cancer	7.48e-05	0.00125	CbGpPWpGaD
Bezafibrate—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	7.43e-05	0.00124	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—PPARG—colon cancer	7.07e-05	0.00118	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.9e-05	0.00115	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—EP300—colon cancer	6.8e-05	0.00114	CbGpPWpGaD
Bezafibrate—PPARA—Circadian rythm related genes—TP53—colon cancer	6.79e-05	0.00114	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.52e-05	0.00109	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PPARG—colon cancer	6.31e-05	0.00105	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—HNF4A—colon cancer	5.97e-05	0.000997	CbGpPWpGaD
Bezafibrate—PPARD—Generic Transcription Pathway—MYC—colon cancer	5.62e-05	0.000939	CbGpPWpGaD
Bezafibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	5.61e-05	0.000937	CbGpPWpGaD
Bezafibrate—CYP1A1—PPARA activates gene expression—EP300—colon cancer	5.44e-05	0.000909	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.43e-05	0.000907	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.42e-05	0.000906	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ODC1—colon cancer	5.41e-05	0.000904	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CHST5—colon cancer	5.41e-05	0.000904	CbGpPWpGaD
Bezafibrate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	5.32e-05	0.000889	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ABCB1—colon cancer	5.3e-05	0.000886	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—TYMS—colon cancer	5.21e-05	0.00087	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—CTNNB1—colon cancer	4.97e-05	0.000831	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.96e-05	0.00083	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CHST5—colon cancer	4.96e-05	0.000828	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ODC1—colon cancer	4.96e-05	0.000828	CbGpPWpGaD
Bezafibrate—PPARG—Circadian rythm related genes—TP53—colon cancer	4.87e-05	0.000814	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	4.87e-05	0.000813	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—PPARG—colon cancer	4.74e-05	0.000793	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EP300—colon cancer	4.62e-05	0.000773	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.51e-05	0.000754	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—SRC—colon cancer	4.5e-05	0.000751	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ABCB1—colon cancer	4.42e-05	0.000738	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CA7—colon cancer	4.39e-05	0.000734	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—VEGFA—colon cancer	4.38e-05	0.000732	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—TYMS—colon cancer	4.34e-05	0.000725	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—NRAS—colon cancer	4.33e-05	0.000723	CbGpPWpGaD
Bezafibrate—PPARA—Generic Transcription Pathway—MYC—colon cancer	4.28e-05	0.000715	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.13e-05	0.00069	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ABCB1—colon cancer	4.04e-05	0.000675	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—TGFB1—colon cancer	4.02e-05	0.000672	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.01e-05	0.00067	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—TYMS—colon cancer	3.97e-05	0.000663	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—EGFR—colon cancer	3.94e-05	0.000659	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—KRAS—colon cancer	3.72e-05	0.000622	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PPARG—colon cancer	3.69e-05	0.000617	CbGpPWpGaD
Bezafibrate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	3.67e-05	0.000613	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—PPARG—colon cancer	3.61e-05	0.000604	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—CTNNB1—colon cancer	3.56e-05	0.000596	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.56e-05	0.000595	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.56e-05	0.000595	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.34e-05	0.000558	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EP300—colon cancer	3.31e-05	0.000554	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—SRC—colon cancer	3.22e-05	0.000538	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—HRAS—colon cancer	3.16e-05	0.000529	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—colon cancer	3.14e-05	0.000524	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NRAS—colon cancer	3.1e-05	0.000518	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPARG—colon cancer	3.07e-05	0.000514	CbGpPWpGaD
Bezafibrate—PPARG—Generic Transcription Pathway—MYC—colon cancer	3.07e-05	0.000513	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.05e-05	0.00051	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.96e-05	0.000495	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—colon cancer	2.9e-05	0.000485	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCB1—colon cancer	2.9e-05	0.000484	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TGFB1—colon cancer	2.88e-05	0.000481	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—TYMS—colon cancer	2.84e-05	0.000475	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—EGFR—colon cancer	2.82e-05	0.000472	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PPARG—colon cancer	2.81e-05	0.00047	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.8e-05	0.000468	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—colon cancer	2.79e-05	0.000467	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MYC—colon cancer	2.71e-05	0.000452	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—KRAS—colon cancer	2.67e-05	0.000446	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CHST5—colon cancer	2.66e-05	0.000445	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ODC1—colon cancer	2.66e-05	0.000445	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—colon cancer	2.42e-05	0.000404	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—EP300—colon cancer	2.41e-05	0.000403	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.33e-05	0.000389	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCB1—colon cancer	2.28e-05	0.000381	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—HRAS—colon cancer	2.27e-05	0.000379	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—TYMS—colon cancer	2.24e-05	0.000374	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.23e-05	0.000373	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—colon cancer	2.21e-05	0.000369	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.19e-05	0.000366	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MYC—colon cancer	2.06e-05	0.000344	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.05e-05	0.000342	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—EP300—colon cancer	2.01e-05	0.000336	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—colon cancer	2e-05	0.000335	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—colon cancer	1.88e-05	0.000313	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—EP300—colon cancer	1.84e-05	0.000307	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PIK3CA—colon cancer	1.79e-05	0.000298	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.76e-05	0.000293	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.72e-05	0.000288	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.61e-05	0.000269	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—colon cancer	1.59e-05	0.000265	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—colon cancer	1.58e-05	0.000265	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CA—colon cancer	1.49e-05	0.000249	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MYC—colon cancer	1.48e-05	0.000247	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.46e-05	0.000244	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—colon cancer	1.46e-05	0.000244	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—colon cancer	1.43e-05	0.000239	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCB1—colon cancer	1.43e-05	0.000239	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—TYMS—colon cancer	1.4e-05	0.000235	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CA—colon cancer	1.36e-05	0.000227	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.34e-05	0.000224	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—EP300—colon cancer	1.32e-05	0.00022	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCB1—colon cancer	1.31e-05	0.000219	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—TYMS—colon cancer	1.29e-05	0.000215	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—colon cancer	1.25e-05	0.000209	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—colon cancer	1.22e-05	0.000203	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—colon cancer	1.11e-05	0.000186	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.08e-05	0.000181	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—EP300—colon cancer	1.04e-05	0.000173	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—colon cancer	1.02e-05	0.000171	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—colon cancer	9.94e-06	0.000166	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	9.91e-06	0.000166	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CA—colon cancer	9.75e-06	0.000163	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—colon cancer	9.11e-06	0.000152	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—colon cancer	7.96e-06	0.000133	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—colon cancer	7.82e-06	0.000131	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CA—colon cancer	7.68e-06	0.000128	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—colon cancer	7.17e-06	0.00012	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCB1—colon cancer	7.03e-06	0.000118	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—TYMS—colon cancer	6.91e-06	0.000115	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—EP300—colon cancer	6.5e-06	0.000109	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—colon cancer	6.27e-06	0.000105	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—EP300—colon cancer	5.96e-06	9.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—colon cancer	4.89e-06	8.18e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CA—colon cancer	4.81e-06	8.04e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CA—colon cancer	4.41e-06	7.37e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—colon cancer	3.93e-06	6.57e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—colon cancer	3.85e-06	6.43e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—colon cancer	3.6e-06	6.02e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—EP300—colon cancer	3.2e-06	5.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CA—colon cancer	2.37e-06	3.96e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—colon cancer	1.93e-06	3.23e-05	CbGpPWpGaD
